[go: up one dir, main page]

EG18341A - Process for preparing of antihypercholesterolemic tetrazole compounds - Google Patents

Process for preparing of antihypercholesterolemic tetrazole compounds

Info

Publication number
EG18341A
EG18341A EG107/88A EG10788A EG18341A EG 18341 A EG18341 A EG 18341A EG 107/88 A EG107/88 A EG 107/88A EG 10788 A EG10788 A EG 10788A EG 18341 A EG18341 A EG 18341A
Authority
EG
Egypt
Prior art keywords
preparing
tetrazole compounds
antihypercholesterolemic
antihypercholesterolemic tetrazole
compounds
Prior art date
Application number
EG107/88A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of EG18341A publication Critical patent/EG18341A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EG107/88A 1987-02-25 1988-02-24 Process for preparing of antihypercholesterolemic tetrazole compounds EG18341A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1854287A 1987-02-25 1987-02-25
US07/151,513 US4897490A (en) 1987-02-25 1988-02-18 Antihypercholesterolemic tetrazole compounds

Publications (1)

Publication Number Publication Date
EG18341A true EG18341A (en) 1993-08-30

Family

ID=26691223

Family Applications (1)

Application Number Title Priority Date Filing Date
EG107/88A EG18341A (en) 1987-02-25 1988-02-24 Process for preparing of antihypercholesterolemic tetrazole compounds

Country Status (31)

Country Link
US (1) US4897490A (pt)
JP (1) JP2603324B2 (pt)
KR (1) KR960001203B1 (pt)
CN (1) CN1026110C (pt)
AT (1) AT395589B (pt)
AU (1) AU1395088A (pt)
BE (1) BE1002116A3 (pt)
CA (1) CA1328268C (pt)
CH (1) CH676848A5 (pt)
CS (1) CS271481B2 (pt)
DE (1) DE3805801C2 (pt)
DK (1) DK174822B1 (pt)
EG (1) EG18341A (pt)
ES (2) ES2010246A6 (pt)
FI (1) FI96601C (pt)
FR (1) FR2612924B1 (pt)
GR (1) GR1000472B (pt)
HU (3) HU204038B (pt)
IE (1) IE61619B1 (pt)
IL (1) IL85529A (pt)
IT (1) IT1216751B (pt)
LU (1) LU87144A1 (pt)
MX (1) MX9202847A (pt)
MY (1) MY103214A (pt)
NL (1) NL8800465A (pt)
NO (1) NO169438C (pt)
NZ (1) NZ223620A (pt)
PT (1) PT86820B (pt)
SE (1) SE503618C2 (pt)
WO (1) WO1988006584A1 (pt)
YU (1) YU36388A (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
US4824959A (en) * 1988-02-18 1989-04-25 Bristol-Myers Company Intermediates for antihypercholesterolemic tetrazole compounds
GB2244706B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole intermediates
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
US4927944A (en) * 1988-08-25 1990-05-22 Bristol-Myers Company Antihypercholesterolemic nitrile compounds
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5413935A (en) * 1991-04-24 1995-05-09 E. R. Squibb & Sons, Inc. Process for selecting an enantiomer of a hydroxy lactone using pseudomonas lipase
US5134155A (en) * 1991-08-08 1992-07-28 Ortho Pharmaceutical Corporation Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors
US5986095A (en) * 1992-01-06 1999-11-16 E.R. Squibb & Sons, Inc. Enantioselective preparation of halophenyl alcohols and acylates
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
JPH06329679A (ja) * 1993-01-20 1994-11-29 Nissan Chem Ind Ltd 光学活性β−アミノアルコキシボラン錯体
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE19714343A1 (de) 1997-04-08 1998-10-15 Bayer Ag Chromatographische Enantiomerentrennung von Lactonen
ATE360608T1 (de) * 1997-12-19 2007-05-15 Pfizer Ireland Pharmaceuticals Verfahren zur herstellung von 1,3-diolen
DE10216967A1 (de) * 2002-04-16 2003-11-13 Bayer Ag Verfahren zur Herstellung spezieller aromatischer Aldehyde
EP2178846A1 (en) * 2007-07-12 2010-04-28 Teva Pharmaceutical Industries Ltd. Rosuvastatin intermediates and their preparation
KR101681041B1 (ko) 2015-07-15 2016-12-22 경북대학교병원 ＥＲＲγ 비활성화 리간드로서의 신규한 방향족 고리 화합물 유도체

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160100A (en) * 1973-03-23 1979-07-03 American Home Products Corporation Oxamic acid derivatives
US4054666A (en) * 1973-03-23 1977-10-18 American Home Products Corporation Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives
US4013647A (en) * 1976-03-23 1977-03-22 American Home Products Corporation Morpholine containing tetrazole-5-carboxamide derivatives
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
NZ194557A (en) * 1979-08-17 1984-09-28 Merck & Co Inc Substituted pyranone derivatives;dihydroxy acids therefrom;pharmaceutical compositions
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
EP0096025A1 (de) * 1981-12-10 1983-12-21 BAYER, Willy Verbrennungsmotor
HU204253B (en) * 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
ES8609193A1 (es) * 1983-01-24 1986-07-16 Sandoz Ag Procedimiento para preparar analogos de mevalonolactona y derivados de los mismos
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
DE3582674D1 (de) * 1984-06-22 1991-05-29 Sandoz Ag Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung.
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
US4621099A (en) * 1985-09-23 1986-11-04 Usv Pharmaceutical Corporation Polyene compounds useful in the treatment of allergic responses
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds

Also Published As

Publication number Publication date
CN1026110C (zh) 1994-10-05
FI96601C (fi) 1996-07-25
DK174822B1 (da) 2003-12-08
SE8800638D0 (sv) 1988-02-24
WO1988006584A1 (en) 1988-09-07
LU87144A1 (fr) 1988-09-20
MX9202847A (es) 1992-06-30
CA1328268C (en) 1994-04-05
NL8800465A (nl) 1988-09-16
NO880809D0 (no) 1988-02-24
FR2612924A1 (fr) 1988-09-30
IT1216751B (it) 1990-03-08
IE880501L (en) 1988-08-25
MY103214A (en) 1993-05-29
HU900669D0 (en) 1990-06-28
ATA46188A (de) 1992-06-15
ES2010246A6 (es) 1989-11-01
HU896737D0 (en) 1990-02-28
HUT47259A (en) 1989-02-28
FI880869A0 (fi) 1988-02-24
IT8819525A0 (it) 1988-02-24
GR880100101A (en) 1988-12-16
YU36388A (en) 1989-10-31
KR960001203B1 (ko) 1996-01-24
FI880869A (fi) 1988-08-26
NO169438B (no) 1992-03-16
HU203329B (en) 1991-07-29
DE3805801C2 (de) 2001-03-01
DK97288A (da) 1988-08-26
NZ223620A (en) 1991-07-26
IL85529A (en) 1993-01-31
HU204516B (en) 1992-01-28
HU204038B (en) 1991-11-28
GR1000472B (el) 1992-07-30
JP2603324B2 (ja) 1997-04-23
FR2612924B1 (fr) 1991-01-11
CN88100911A (zh) 1988-09-28
JPH01502269A (ja) 1989-08-10
AU1395088A (en) 1988-09-26
KR880009947A (ko) 1988-10-06
PT86820B (pt) 1995-03-01
PT86820A (pt) 1989-02-28
IL85529A0 (en) 1988-08-31
BE1002116A3 (fr) 1990-07-10
CS118088A2 (en) 1989-08-14
SE8800638L (sv) 1988-09-21
CH676848A5 (pt) 1991-03-15
US4897490A (en) 1990-01-30
SE503618C2 (sv) 1996-07-15
DK97288D0 (da) 1988-02-24
NO169438C (no) 1992-06-24
NO880809L (no) 1988-08-26
CS271481B2 (en) 1990-10-12
DE3805801A1 (de) 1988-09-08
FI96601B (fi) 1996-04-15
IE61619B1 (en) 1994-11-16
ES2026746A6 (es) 1992-05-01
AT395589B (de) 1993-01-25

Similar Documents

Publication Publication Date Title
EG18398A (en) Process for preparing of piperazinyl-heterocyclic compounds
EG18341A (en) Process for preparing of antihypercholesterolemic tetrazole compounds
YU92788A (en) Process for obtaining pharmaceutic compound of cephuroxime axetyl
YU173088A (en) Process for obtaining trans-mucosalic compounds
YU191188A (en) Process for preparing new ammonia compounds
IL119366A0 (en) Process for preparing certain substituted tetrazole compounds
YU202889A (en) Process for obtaining heterocyclical compounds
YU228688A (en) Process for preparing new ammonia compounds
YU30388A (en) Process for obtaining arylpiperazinylalkylenephenyl-heterocyclic compounds
YU24088A (en) Process for preparing heterocyclical compounds
PT85675A (en) Process for preparing delta 22-derivatives of ll-28249 compounds
GB2203153B (en) Process for preparing sulphonated organosilicon compounds
EP0314618A3 (en) Process for the preparation of organometallic compounds
GB8804281D0 (en) Intermediates & processes for preparation of antihypercholesterolemic tetrazole compounds
ZA887833B (en) Process for purification of soluble t4
GB8827831D0 (en) Compositions for reduction of phlebectasiae & process for preparing same
GB2202846B (en) Antihypercholesterolemic tetrazole compounds
HU902054D0 (en) Process for producing medical preparatives containing known compounds
HUT48254A (en) Process for producing macrolid compounds
HUT48257A (en) Process for producing makrolid compounds
YU145289A (en) Process for obtaining antihipercholesterole derivatives of tetrazole
PT86534A (en) Process for preparing 2-heterocyclylalkyl-2-penem compounds
IL105487A0 (en) Process for the preparation of antihypercholesterolemic compounds
ZA881278B (en) Intermediates and processes for the preparation of antihypercholesterolemic tetrazole compounds
HRP940253A2 (en) Process for preparing substituted propan-phosphine acid compounds